DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

DOK7 congenital myasthenic syndrome in childhood: Early diagnostic clues in 23 children

Toon andere (1) versies

Mutations in DOK7 are a common cause of congenital myasthenia. Treatment with ephedrine or salbutamol is effective, but diagnosis is often delayed. The aim of our study was to find early clues to the diagnosis of DOK7 congenital myasthenic syndrome. We included 23 children of 20 families. Onset of s...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Klein, A, Pitt, M, McHugh, J, Niks, E, Sewry, C, Phadke, R, Feng, L, Manzur, A, Tirupathi, S, DeVile, C, Jayawant, S, Finlayson, S, Palace, J, Muntoni, F, Beeson, D, Robb, SA
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2013

Gelijkaardige items

DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children.
door: Klein, A, et al.
Gepubliceerd in: (2013)

Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
door: Burke, G, et al.
Gepubliceerd in: (2013)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
door: Lashley, D, et al.
Gepubliceerd in: (2010)

Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome.
door: Jephson, C, et al.
Gepubliceerd in: (2010)

DOK7 congenital myasthenic syndrome.
door: Palace, J
Gepubliceerd in: (2012)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
door: Kinali, M, et al.
Gepubliceerd in: (2008)

The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome.
door: Cossins, J, et al.
Gepubliceerd in: (2012)

Congenital myasthenic syndromes: an update.
door: Finlayson, S, et al.
Gepubliceerd in: (2013)

Dok-7/MuSK signaling and a congenital myasthenic syndrome.
door: Yamanashi, Y, et al.
Gepubliceerd in: (2008)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
door: Lashley, D, et al.
Gepubliceerd in: (2009)

Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
door: Müller, J, et al.
Gepubliceerd in: (2007)

DOK7 Mutations in Congenital Myasthenic Syndromes
door: J Gordon Millichap
Gepubliceerd in: (2007-06-01)

The spectrum of mutations that underlie the DOK7 neuromuscular junction synaptopathy, and the patient response to treatment
door: Beeson, D, et al.
Gepubliceerd in: (2012)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
door: Lashley, D, et al.
Gepubliceerd in: (2009)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
door: Burke, G, et al.
Gepubliceerd in: (2006)

Clinical features of the DOK7 neuromuscular junction synaptopathy.
door: Palace, J, et al.
Gepubliceerd in: (2007)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
door: Finlayson, S, et al.
Gepubliceerd in: (2016)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
door: Beeson, D, et al.
Gepubliceerd in: (2006)

The congenital myasthenic syndromes.
door: Palace, J, et al.
Gepubliceerd in: (2008)

Ephedrine treatment in DOK7 CMS and investigation of potential mechanisms
door: Cossins, J, et al.
Gepubliceerd in: (2010)

Congenital myasthenic syndromes.
door: Beeson, D, et al.
Gepubliceerd in: (1997)

DOK7 congenital myasthenic syndrome: case series and review of literature
door: Bentolhoda Ziaadini, et al.
Gepubliceerd in: (2024-06-01)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
door: Finlayson, S, et al.
Gepubliceerd in: (2012)

Congenital myasthenic syndromes and the neuromuscular junction.
door: Cruz, P, et al.
Gepubliceerd in: (2014)

Therapeutic strategies for congenital myasthenic syndromes
door: Lee, M, et al.
Gepubliceerd in: (2018)

Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome
door: Clausen, L
Gepubliceerd in: (2015)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
door: Jorge A. Bevilacqua, et al.
Gepubliceerd in: (2017-09-01)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
door: Healy, E, et al.
Gepubliceerd in: (2014)

Congenital myasthenic syndrome caused by mutations in DPAGT.
door: Klein, A, et al.
Gepubliceerd in: (2015)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
door: Finlayson, S, et al.
Gepubliceerd in: (2013)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
door: Belaya, K, et al.
Gepubliceerd in: (2012)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
door: Rodríguez Cruz, P, et al.
Gepubliceerd in: (2018)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
door: Finlayson, S, et al.
Gepubliceerd in: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
door: Finlayson, S, et al.
Gepubliceerd in: (2013)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
door: Mewasingh, L, et al.
Gepubliceerd in: (2006)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
door: Chaouch, A, et al.
Gepubliceerd in: (2012)

Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
door: Munot, P, et al.
Gepubliceerd in: (2010)

Therapy of myasthenic syndrome
door: Palace, J
Gepubliceerd in: (2012)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
door: Palace, J
Gepubliceerd in: (2010)

Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
door: Hamuro, J, et al.
Gepubliceerd in: (2008)